Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Paxmedica Inc (NQ: PXMD )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Paxmedica Inc

< Previous 1 2 3 4 Next >
PaxMedica Inc. (NASDAQ: PXMD) Shares Corporate Update and Commitment to Advancing Therapies for Neurological Disorders, Prepares for Key Engagements with the FDA
Via Investor Brand Network
Study Discovers Elevated Risk of Toxicity Among Autistic Kids
Via Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis
Via Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Dedicated to Ensuring Access to Life-Saving Treatments
Via Investor Brand Network
Researcher Wants to Untangle Environmental, Genetic Complexities of Autism
Via Investor Brand Network
Rising Cases of Autism in UK Raise Concerns
Via Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Appeals NASDAQ Delisting Decision, Prepares for June FDA Meeting
Via Investor Brand Network
Exposures Product Safety
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
From PaxMedica, Inc.
Via GlobeNewswire
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Continues Advancement of PAX-101 Regulatory Strategy
Via Investor Brand Network
Exposures Product Safety
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
From PaxMedica, Inc.
Via GlobeNewswire
PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Featured in Latest Bell2Bell Podcast Release
Via Investor Brand Network
“Urgent Action: PaxMedica Inc. (NASDAQ: PXMD) Addresses Medical Crisis in Malawi”
Via Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDA
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Responds to Emergency Request for IV Suramin, Commits to Provide Immediate Access to PAX-101
Via Investor Brand Network
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
From PaxMedica, Inc.
Via GlobeNewswire
Misinformation on TikTok Causing Many to Misdiagnose Themselves as Autistic
Via Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) in Process of Responding to Emergency Request for IV Suramin from African Health Ministry
Via Investor Brand Network
Exposures Product Safety
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
From PaxMedica, Inc.
Via GlobeNewswire
InvestorNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Announces ‘Milestone Achievement’ on Journey to Developing PAX-101
Via Investor Brand Network
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
From PaxMedica, Inc.
Via GlobeNewswire
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Developing Robust Product Lineup to Address ASD, Associated Neurodevelopmental Conditions
Via Investor Brand Network
Prenatal Exposure to Caffeine and High-Fat Diets Heighten Autism Risk in Rodent Models
Via Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Developing Pipeline to Address Unmet Needs in Autism Spectrum Disorder via Suramin Sodium
Via Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) on Promising Path to Meet Medical Needs of ASD Patients
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Shares Vision, Innovations in ASD Treatments in Updated Company Presentation
Via Investor Brand Network
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
From PaxMedica, Inc.
Via GlobeNewswire
PaxMedica Inc. (NASDAQ: PXMD) Pursues Autism Treatment as Diagnostic App Shows Promise to Effective ASD Diagnosis
Via Investor Brand Network
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Committed to Developing Groundbreaking Therapies, Transformative Solutions
Via Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Developing Pipeline of Products to Address Prevalence and Unmet Medical Needs of Autism Spectrum Disorder
Via Investor Brand Network
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.